4.5 Article

FOXL2 Is Involved in the Synergy between Activin and Progestins on the Follicle-Stimulating Hormone β-Subunit Promoter

Journal

ENDOCRINOLOGY
Volume 153, Issue 4, Pages 2023-2033

Publisher

ENDOCRINE SOC
DOI: 10.1210/en.2011-1763

Keywords

-

Funding

  1. NCI Cancer Center [P30 CA023100]
  2. National Institutes of Health (NIH) [K01 DK080467, R01 HD067448]
  3. Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54 HD012303, R01s HD020377, DK044838]
  4. Endocrine Society
  5. [P30 DK063491]
  6. [P42 ES010337]

Ask authors/readers for more resources

Differential regulation of gonadotropin hormone production in the pituitary is critical for fertility. Activin and progesterone signaling in gonadotrope cells is important for Fshb gene expression. Previously, we reported that synergy between activin and progestins required the binding of SMAD proteins and the progesterone receptor (PR) to the murine Fshb promoter. In this study, we demonstrate that the FOXL2 transcription factor is also necessary for the full synergistic response between activin and progestins. We show that this synergy occurs in a species-specific manner and that multiple elements in the Fshb promoter that bind forkhead box L2 (FOXL2), SMA/mothers against decapentaplegic homologs (SMAD), and PR are required. Furthermore, we demonstrate that FOXL2 can physically interact with PR and SMAD3. Thus, it is likely that protein-protein interactions among FOXL2, SMAD, and PR recruited to the Fshb promoter play a key role in facilitating Fshb transcription before the secondary FSH surge in rodents. (Endocrinology 153: 2023-2033, 2012)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available